On the other hand, a polymorphic CAG-repeat length in the AIB1, a coactivator of the oestrogen receptor, was found to modify BC risk in BRCA1 carriers (Rebbeck et al, 2001; Kadouri et al, 2004b). Here, NCOA3 is linked to breast cancer.